Botulism from Chopped Garlic: Delayed Recognition of a Major Outbreak

  1. MICHAEL E. ST. LOUIS, M.D.;
  2. SHAUN H.S. PECK, M.B., F.R.C.P.;
  3. DAVID BOWERING, M.D.;
  4. G. BARRY MORGAN, B.S.A.;
  5. JOHN BLATHERWICK, M.D., F.R.C.P.;
  6. SATYEN BANERJEE, Ph.D.;
  7. G.D.M. KETTYLS, M.D. F.R.C.P.;
  8. W.A. BLACK, M.D. F.R.C.P.;
  9. MAY E. MILLING, M.S.A.;
  10. ANDRE H.W. HAUSCHILD, Ph.D.;
  11. ROBERT V. TAUXE, M.D.; and
  12. PAUL A. BLAKE, M.D., M.P.H.
  1. Atlanta, Georgia; Vancouver and Victoria, British Columbia; and Ottawa, Ontario

    Abstract

    Diagnosis of botulism in two teenaged sisters in Montreal led to the identification of 36 previously unrecognized cases of type B botulism in persons who had eaten at a restaurant in Vancouver, British Columbia, during the preceding 6 weeks. A case-control study implicated a new vehicle for botulism, commercial chopped garlic in soybean oil (P < 10-4). Relatively mild and slowly progressive illness, dispersion of patients over at least eight provinces and states in three countries, and a previously unsuspected vehicle had contributed to prolonged misdiagnoses, including myasthenia gravis (six patients), psychiatric disorders (four), stroke (three), and others. Ethnic background influenced severity of illness: 60% of Chinese patients but only 4% of others needed mechanical ventilation (P < 10-3). Trypsinization of serum was needed to show toxemia in one patient. Electromyography results with high-frequency repetitive stimulation corroborated the diagnosis of botulism up to 2 months after onset. Although botulism is a life-threatening disease, misdiagnosis may be common and large outbreaks can escape recognition completely.

    Article and Author Information

    • ▸From the Enteric Diseases Branch, Division of Bacterial Diseases, Centers for Disease Control, Atlanta, Georgia; Vancouver Health Department, City of Vancouver, British Columbia; Division of Epidemiology, Ministry of Health, Victoria, British Columbia; Health Protection Branch, Health and Welfare Canada, Burnaby, British Columbia; British Columbia Provincial Laboratories, Vancouver, British Columbia; Division of Field Epidemiology, Bureau of Communicable Disease Epidemiology, Laboratory Center for Disease Control, Ottawa, Ontario; and Botulism Reference Service, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario.

    • ▸Requests for reprints should be addressed to Michael St. Louis, M.D.; CID:DBD:EDB 1-5428, Centers for Disease Control, Atlanta, GA 30333.

    « Previous | Next Article »Table of Contents